ER Squibb & Sons delved into cancer research, discovering and developing hydroxyurea for leukemia and advanced ovarian cancer - LifeScienceHistory.com

ER Squibb & Sons delved into cancer research, discovering and developing hydroxyurea for leukemia and advanced ovarian cancer

Biotechnology, Oncology, Women’s Health

In 1967, E.R. Squibb & Sons delved into cancer research, discovering and developing hydroxyurea for leukemia and advanced ovarian cancer.

Tags:

cancer, leukemia, ovarian cancer

Source: Bristol-Myers Squibb Company
Credit:

Visit News/History Source

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.